Eberhard Karls Universität Tübingen

Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition (2018) Siebzehnrubl FA, Reber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, Habermeyer J, et al. Journal article Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes, prediabetes and healthy controls from the general population (2018) Kiefer LS, Fabian J, Rospleszcz S, Lorbeer R, Machann J, Storz C, Kraus MS, et al. Journal article Phosphorylation of the neurogenic transcription factor SOX11 on serine 133 modulates neuronal morphogenesis (2018) Balta EA, Schäffner I, Wittmann MT, Sock E, Von Zweydorf F, von Wittgenstein J, Steib K, et al. Journal article Phosphorylation Modulates the Subcellular Localization of SOX11 (2018) Balta EA, Wittmann MT, Jung M, Sock E, Häberle B, Heim B, Von Zweydorf F, et al. Journal article Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma (2018) Werner-Klein M, Scheitler S, Hoffmann M, Hodak I, Dietz K, Lehnert P, Naimer V, et al. Journal article Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study (2018) Jaeger VK, Siegert E, Hachulla E, Airo P, Valentini G, Matucci-Cerinic M, Scorza R, et al. Conference contribution LOOSING DAS28-ESR, BUT STAYING IN BOOLEAN REMISSION-IS IT POSSIBLE? DATA FROM THE PROSPECTIVE, RANDOMISED RETRO TRIAL ON RHEUMATOID ARTHRITIS PATIENTS IN STABLE REMISSION (2018) Erhard J, Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, et al. Conference contribution Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Whither systems medicine? (2018) Apweiler R, Beissbarth T, Berthold MR, Bluethgen N, Burmeister Y, Dammann O, Deutsch A, et al. Journal article Fear of cancer progression in patients with stage IA malignant melanoma (2018) Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al. Journal article